SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
7780>>The implication is that the market currently thinks those results [i.e. Icebrg-11/5/2004
7779Aww, c'mon. You haven't even looked at the IVs of the options yet! FWItuck-11/5/2004
7778I don't like this game. I'm not playing. I'm gonna take my spreadshebio_kruncher-11/5/2004
7777Some wild guesses: Outcome - Price Dec - Price Jan .85 Approval - 63 - 67 .05 Dfred hayes-11/5/2004
7776Very quiet here. OK, I'll start the guessing game. We are a little under Rocky9-11/5/2004
7775From Schaeffer earlier today: Options speculators loaded up on Sepracor (NasdaqRocky9-10/27/2004
7774Well, Kerry wants US citizens to buy drugs from Canada and I recall that SepracoHarold Engstrom-10/27/2004
7773JP Morgan adds SEPR to its Focus List: Too many of us remember the JPM report fRocky9-10/27/2004
7772Lilly Acquires Novel Compound for Insomnia from Merck KGaA Wednesday October 27,Icebrg-10/27/2004
7771If Kerry wins and Estorra approved, SEPR can fire the 1250 reps and sell directljayhawk969-10/26/2004
7770Nine month increase in sales of Xopenex 202.6 vs 186.6 prior year. 3 months compjayhawk969-10/26/2004
7769phoenix.corporate-ir.net Sepracor Announces Third Quarter 2004 Operating Resultquidditch-10/26/2004
7768In case people were wondering why the most recent SEPR convertible is mostly setBiomaven-10/22/2004
7767Piper Jaffray SEPR $43.80 - OP - Mkt Cap (mil) = $3,801.8 Waiting On Estorra, Icebrg-10/20/2004
7766Thanks for updating. Pretty negative, which of course goes with the "sell&kenhott-10/14/2004
7765Q2 call mentioned some imo weak reasons for the xopenex shortfall: <<O&#rkrw-10/14/2004
7764<i>On Xopenex front, MS just slashed estimates saying uptake is not happenjayhawk969-10/14/2004
7763They did not like the option bet SEPR made on itself nor the constant stream of Robohogs-10/14/2004
7762Would appreciate more info about what not to like about capital structure from Skenhott-10/13/2004
7761You could say that. And it seems the mkt listens when SSB talks. Ouch! I wantRobohogs-10/13/2004
7760<<<SSB is out with initiation at Sell. Target $40. Does not like Estorrrkrw-10/13/2004
7759SSB is out with initiation at Sell. Target $40. Does not like Estorra challengRobohogs-10/13/2004
77588-K: Item 8.01 Other Events On October 1, 2004, Sepracor Inc. (the “Registrantquidditch-10/8/2004
7757Sustained efficiency of Esciplicone over 6 months….radomised, double-blind, placA.J. Mullen-10/2/2004
7756I don't see a next gen zyrtec as having much potential. Maybe Pfizer lets rkrw-10/1/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News